<s> Cetus Corp. said the government of Spain approved the marketing of its Proleukin interleukin-2 drug to treat kidney cancer . </s>
<s> The biotechnology concern said Spanish authorities must still clear the price for the treatment , but that it expects to receive such approval by year end . </s>
<s> Four other countries in Europe have approved Proleukin in recent months . </s>
<s> Cetus is currently trying to obtain federal regulatory clearance for U.S. distribution . </s>
